N4 Pharma Plc
N4P.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£1,120 | -£1,269 | -£1,029 | -£1,544 |
| Dep. & Amort. | £0 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £7 | £3 | £24 | £17 |
| Change in WC | £33 | £48 | -£172 | £54 |
| Other Non-Cash | £108 | £9 | £349 | -£299 |
| Operating Cash Flow | -£972 | -£1,209 | -£828 | -£1,772 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | £0 | £0 | £0 |
| Net Acquisitions | £0 | £1 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | £0 | £1 | £0 | £0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £630 | £350 | £1,054 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£60 | -£34 | -£90 | £1 |
| Financing Cash Flow | £570 | £316 | £964 | £1 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | -£401 | -£892 | £136 | -£1,772 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £1,027 | £1,920 | £1,784 | £3,556 |
| End Cash | £626 | £1,027 | £1,920 | £1,784 |
| Free Cash Flow | -£972 | -£1,209 | -£828 | -£1,772 |